올리디아 (Olidia)

팝업레이어 알림

팝업레이어 알림이 없습니다.

ENG

KOR

ENG

KOR

ENG

Olidia

Wrinkle

Science

Olidia®
Wrinkle Science

Certified by European CE, approved by Korea FDA
Confidence begins with Olidia.

"For the temporary improvement of nasolabial folds"

PLLA FILLER

Safe Filler Olidia®

Biodegradable PLLA Material

PLLA FILLER

Difference in
advanced technology

Olidia® is a safe filler that improves nasolabial folds by filling from within the skin.

PLLA Filler

Composition

Biodegradable Poly-L-Lactic Acid (PLLA)
Advanced PSPCM Technology
PLLA Microspheres

PSPCM

The name is an abbreviation for the main components
of Olidia by PRPscience: PLLA + CMC + Mannitol.

Consistent

Uniform and
Consistent Size

PLLA

Microspherical
PLLA Technology

3Types

Three Products Based
on PLLA Content

Ratio

Optimal Ratio
of Components:
PLLA + CMC + Mannitol

Learn more

Olidia

Product Name	Olidia
Key Ingredients	PLLA + CMC + Mannitol
Dose	365mg
Treatment Layer	Subcutaneous layer

Learn more

Olidia 240

Product Name	Olidia
Key Ingredients	PLLA + CMC + Mannitol
Dose	243.4mg
Treatment Layer	Subdermal layer

Learn more

Olidia 120

Product Name	Olidia
Key Ingredients	PLLA + CMC + Mannitol
Dose	121.7mg
Treatment Layer	Subdermal layer

Olidia

Product Name	Olidia
Key Ingredients	PLLA + CMC + Mannitol
Dose	365mg
Treatment Layer	Subcutaneous layer

Olidia 240

Product Name	Olidia
Key Ingredients	PLLA + CMC + Mannitol
Dose	243.4mg
Treatment Layer	Subdermal layer

Olidia 120

Product Name	Olidia
Key Ingredients	PLLA + CMC + Mannitol
Dose	121.7mg
Treatment Layer	Subdermal layer

Customer

FAQ

What medical procedures is Olidia used for?

Olidia uses Poly-L-Lactic Acid (PLLA) and is injected into the dermis or subcutaneous tissue to physically restore and temporarily improve moderate to severe nasolabial folds in adults.

What precautions should be taken after the procedu…

Needle marks from the procedure generally disappear within a few days, and bruising and swelling may occur but typically improve naturally within a few hours to a few days. After the procedure, you should avoid drinking alcohol, smoking, using hot baths or saunas, and engaging in excessive exercise for a certain period.

Learn more

Instagram Event

If you have any questions, please ask,
and our representative will respond promptly.

Company

Contact number

E-mail

Inquiry Details

PRP Science Privacy Policy Notice

Purpose and Items of Personal Data Collection
- Purpose of Collection : Personal identification and verification, prevention of misuse by prohibited customers, record retention for dispute resolution, and handling of complaints and inquiries.
- Required Items : Company name, contact information, email.
- Method of Collection : Website (customer inquiries) data collection.

Retention and Processing Period for Personal Data 
In accordance with relevant laws, including the Commercial Act and the Act on the Consumer Protection in Electronic Commerce, PRP Science will retain customer information for the legally specified period when necessary. This data will be used solely for retention purposes. After the retention period, the information will be promptly destroyed.

- Retention Items : Records of customer inquiries, complaints, dispute resolutions, and responses.
- Legal Basis : Consumer Protection in Electronic Commerce Act.
- Retention Period : 3 years.

Notice Regarding Non-Consent 
Consent to provide the above personal information is optional. However, without it, the board entry cannot be completed, making complaint handling unavailable.

Agree to the Collection and Use of Personal Information

Product Information

[Item Name] Tissue Repair Material.

[Model Name] Olidia, Olidia 240, Olidia 120

[Raw Materials] Poly-L-lactic acid.

[Packaging] 1 vial/box.

[Purpose]

To temporarily improve moderate to severe nasolabial folds by injecting a Poly-L-lactic acid suspension into the deep dermis or subcutaneously.

[Precautions]

1. Contraindications

- Do not use until infections and inflammation are resolved.
- Avoid in patients with hypersensitivity to this product or its components.

2. Warnings

- Avoid use in areas where vascular occlusion may occur.
- Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.

3. General Precautions

- Injection into blood vessels may cause serious side effects, such as blindness. We recommend avoiding areas with thin skin and high vascularity, such as glabella and periorbital areas, and exercising extreme caution when injecting into those areas.
- Safety in patients susceptible to keloids, hyperpigmentation, or hypertrophic scars is not established.
- Only trained physicians should perform the procedure.
- Physicians must explain indications, contraindications, and potential side effects to patients prior to use. Ensure that the product is sterile before use.
- Check the expiration date on the product label.
- Injection in patients with a history of herpes eruption may trigger recurrence.
- Long-term safety and efficacy beyond durations verified by clinical study are not confirmed.

References

"Journal of Cosmetics, Dermatological Sciences and Application, 2012, 2, 20-27"

"Polylactic Acid Piezo-Biopolymers: Chemistry, Structural Evolution, Fabrication Methods and Tissue" Engineering Applications"

Factory 1 81-54 Yulam-ri, Paltan-myeon, Hwaseong-si, Gyeonggi-do
Factory 2 453 Oncheon-ro, Paltan-myeon, Hwaseong-si, Gyeonggi-do
Branch #403, 32, Samseong-ro 149-gil, Gangnam-gu, Seoul
Tel. +82 1588 - 2280

Email. prpscoltd@gmail.com

Web. http://www.prpscience.co.kr

ENG

KOR

ENG

This is a "medical device." Read 'caution' and 'instructions' carefully.

Ad review number: 42024-i10-36-3280

(Expires: 27.09.19)

This is a "medical device." Read 'caution' and 'instructions' carefully.

Ad review number: 42024-i10-36-3287

(Expires: 27.10.07)

This is a "medical device." Read 'caution' and 'instructions' carefully.

Ad review number: 42024-i10-39-3694

(Expires: 27.10.08)

This is a "medical device." Read 'caution' and 'instructions' carefully.

Ad review number: 42024-i10-36-3289

(Expires: 27.09.19)